(Q55051058)

16 June 2018

title

Failure of the Merck HIV vaccine: an uncertain step forward. (English)

1 reference

16 June 2018

1

Merlin L Robb

1 reference

16 June 2018

language of work or name

English

0 references

publication date

13 November 2008

1 reference

16 June 2018

published in

The Lancet

1 reference

16 June 2018

volume

372

1 reference

16 June 2018

issue

9653

1 reference

16 June 2018

page(s)

1857-1858

1 reference

16 June 2018

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Prospects for an AIDS vaccine: three big questions, no easy answers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

Male circumcision for prevention of HIV transmission: what the new data mean for HIV prevention in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

HIV vaccine research: the way forward

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961593-7

7 January 2021

10.1016/S0140-6736(08)61593-7

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018